House Panel Probes Wyeth Off-Label Allegations
The House Committee on Oversight and Government Reform has opened an investigation into claims that Wyeth Pharmaceuticals Inc. targeted blacks in an illegal off-label marketing scheme for kidney transplant drug Rapamune....To view the full article, register now.
Already a subscriber? Click here to view full article